Outcomes of Antipsychotic Drug Use in Community-Dwelling Elders With Dementia

Archives of Psychiatric Nursing

Volumn 20, Issue 5, 2006, Pages 217-225

  Kolanowski, Ann ^a   Fick, Donna ^a   Waller, Jennifer L ^b   Ahern, Frank ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; DELIRIUM; DEMENTIA; DEMOGRAPHY; DEPRESSION; DRUG UTILIZATION; FALLING; FEMALE; HEALTH SERVICES RESEARCH; HIP FRACTURE; HUMAN; INSURANCE; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PSYCHIATRIC NURSING; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; SYNCOPE; UNITED STATES;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; DELIRIUM; DEMENTIA; DEPRESSION; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH SERVICES RESEARCH; HIP FRACTURES; HUMANS; INSURANCE CLAIM REPORTING; LOGISTIC MODELS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PSYCHIATRIC NURSING; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SOUTHEASTERN UNITED STATES; SYNCOPE;

EID: 33748936850     PISSN: 08839417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apnu.2006.04.004     Document Type: Article

References (39)

1. Alexopoulos G.S., Streim J., Carpenter D., and Docherty J.P. Using antipsychotic agents in older patients. Journal of Clinical Psychiatry 65 Suppl 2 (2004) 5-99
2. American Society of Health System Pharmacists. AHFS drug information (2005), ASHSP, Bethesda, MD
3. Baldwin R.C., Gallagley A., Gourlay M., Jackson A., and Burns A. Prognosis of late life depression: A three-year cohort study of outcome and potential predictors. International Journal of Geriatric Psychiatry 21 (2006) 57-63
4. Ballard C.G., Thomas A., Fossey J., Lee L., Jacoby R., Lana M.M., et al. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry 65 (2004) 114-119
5. Buchanan R.J., Wang S., Ju H., and Graber D. Analyses of gender differences in profiles of nursing home residents with Alzheimer's disease. Gender Medicine 1 (2004) 48-59
6. Centorrino F., Albert M.J., Drago-Ferrante G., Koukopoulos A.E., Berry J.M., and Baldessarini R.J. Delirium during clozapine treatment: Incidence and associated risk factors. Pharmacopsychiatry 36 (2003) 156-160
7. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases 40 (1987) 373-383
8. Cohen-Mansfield J., Marx M.S., and Rosenthal A.S. A description of agitation in a nursing home. Journal of Gerontology, Series A Biological Sciences and Medical Sciences 44A (1989) M77-M84
9. Donaldson C., Tarrier N., and Burns A. The impact of the symptoms of dementia on caregivers. British Journal of Psychiatry 170 (1997) 62-68
10. Doody R.S., Stevens J.C., Beck C., Dubinsky R.M., Kaye J.A., Gwyther L., et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001) 1154-1166
11. Dyer C.B., Pavlik V.N., Murphy K.P., and Hyman D.J. The high prevalence of depression and dementia in elder abuse or neglect. Journal of the American Geriatric Society 48 (2000) 205-208
12. Everitt D.E., Fields D.R., Soumerai S.S., and Avorn J. Resident behavior and staff distress in the nursing home. Journal of the American Geriatrics Society 39 (1991) 792-798
13. Fialova D., Topinkova E., Gambassi G., Finne-Soveri H., Jonsson P.V., Carpenter I., et al. Potentially inappropriate medication use among elderly home care patients in Europe. Journal of the American Medical Association 293 (2005) 1348-1358
14. Flaherty J.H., Perry III H.M., Lynchard G.S., and Morley J.E. Polypharmacy and hospitalization among older home care patients. Journal of Gerontology. Series A Biological Sciences and Medical Sciences 55 (2000) M554-M559
15. Food Drug Administration. FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients. Retrieved on February 6, 2006, from (2005). http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html
16. Galynker I.I., Roane D.M., Miner C.R., Feinberg T.E., and Watts P. Negative symptoms in patients with Alzheimer's disease. American Journal of Geriatric Psychiatry 3 (1995) 52-59
17. Gill S.S., Rochon P.A., Herrmann N., Lee P.E., Sykora K., Gunraj N., et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. British Medical Journal 330 (2005) 445
18. Hebert L.E., Beckett L.A., Scherr P.A., and Evans D.A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders 15 (2001) 169-173
19. Jensen G.L., Friedmann J.M., Coleman C.D., and Smiciklas-Wright H. Screening for hospitalization and nutritional risks among community-dwelling older persons. American Journal of Clinical Nutrition 74 (2001) 201-205
20. Katz I.R., Rupnow M., Kozma C., and Schneider L. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: Secondary analysis of a double-blind, placebo-controlled trial. American Journal of Geriatric Psychiatry 12 (2004) 499-508
21. Kolanowski A.M., Fick D., Waller J.L., and Shea D. Spouses of persons with dementia: Their healthcare problems, utilization, and costs. Research in Nursing & Health 27 (2004) 296-306
22. Lamb S.E., Jorstad-Stein E.C., Hauer K., and Becker C. Development of a common outcome data set for fall injury prevention trials: The prevention of falls network Europe consensus. Journal of the American Geriatrics Society 53 (2005) 1618-1622
23. Lambert B.L., Chou C.H., Chang K.Y., Tafesse E., and Carson W. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: A matched case-control study of California Medicaid claims. Pharmacoepidemiology and Drug Safety 14 (2005) 417-425
24. Landi F., Onder G., Cesari M., Barillaro C., Russo A., and Bernabei R. Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 60 (2005) 622-626
25. Liperoti R., Mor V., Lapane K.L., Pedone C., Gambassi G., and Bernabei R. The use of atypical antipsychotics in nursing homes. Journal of Clinical Psychiatry 64 (2003) 1106-1112
26. Mayeux R., and Sano M. Treatment of Alzheimer's disease. New England Journal of Medicine 341 (1999) 1670-1679
27. Mitchell J., Mathews H.F., Hunt L.M., Cobb K.H., and Watson R.W. Mismanaging prescription medications among rural elders: The effects of socioeconomic status, health status, and medication profile indicators. Gerontologist 41 (2001) 348-356
28. Murman D.L., Chen Q., Powell M.C., Kuo S.B., Bradley C.J., and Colenda C.C. The incremental direct costs associated with behavioral symptoms in AD. Neurology 59 (2002) 1721-1729
29. Profenno L.A., and Tariot P.N. Pharmacologic management of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 17 (2004) 65-77
30. Rapoport M., Mamdani M., Shulman K.I., Herrmann N., and Rochon P.A. Antipsychotic use in the elderly: Shifting trends and increasing costs. International Journal of Geriatric Psychiatry 20 (2005) 749-753
31. Sink K.M., Holden K.F., and Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. Journal of the American Medical Association 293 (2005) 596-608
32. Starkstein S.E., Jorge R., Mizrahi R., and Robinson R.G. The construct of minor and major depression in Alzheimer's disease. American Journal of Psychiatry 162 (2005) 2086-2093
33. Sultzer D.L. Psychosis and antipsychotic medications in Alzheimer's disease: Clinical management and research perspectives. Dementia and Geriatric Cognitive Disorders 17 (2004) 78-90
34. Taggart L., McCammon S., Allred L., Horner R., and May H. Effect of patient and physician gender on prescriptions for psychotropic drugs. Journal of Women's Health 2 (1993) 353-357
35. Teri L., Logsdon R.G., Peskind E., Raskind M., Weiner M., Tractenberg R.E., et al. Treatment of agitation in Alzheimer's disease: An investigation of haloperidol, trazodone and behavior management techniques. Research and Practice in Alzheimer's Disease and Other Dementias 5 (2001) 27-31
36. van Schoor N.M., Smit J.H., Twisk J.W., Bouter L.M., and Lips P. Prevention of hip fractures by external hip protectors: a randomized. JAMA 289 15 (2003) 1957-1962
37. Veehof L.J., Stewart R.E., Meyboom-de Jong B., and Haaijer-Ruskamp F.M. Adverse drug reactions and polypharmacy in the elderly in general practice. European Journal of Clinical Pharmacology 55 (1999) 533-536
38. Wang P.S., Schneeweiss S., Avorn J., Fischer M.A., Mogun H., Solomon D.H., et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. New England Journal of Medicine 353 (2005) 2335-2341
39. Wooltorton E. Olanzapine (Zyprexa): Increased incidence of cerebrovascular events in dementia trials. Canadian Medical Association Journal 170 (2004) 1395